Irving L. Weissman
Stanford University
1170 Papers
18.9K Citations
Irving L. Weissman is an academic researcher from Stanford University. The author has contributed to research in topics: Stem cell & Haematopoiesis. The author has an hindex of 201, co-authored 1141 publications. Previous affiliations of Irving L. Weissman include Eli Lilly and Company & Memorial Sloan Kettering Cancer Center.
Chat about Author
Papers
Lymphocyte homing receptors and the immune response in vivo.
TL;DR: An important aspect of the developmental maturation of lymphocytes is their capacity to locate and enter lymphoid organs with great rapidity and specificity and to follow certain routes within these organs for the attainment of particular immunological capabilities.
10
Immunity to infections following hematopoietic cell transplantation.
TL;DR: Hematopoietic cell transplantation has progressed from the use of unpurified bone marrow cells or mobilized peripheral blood cells to theUse of purified stem cells and progenitor cells.
10
Patent
SIRPα AGONIST ANTIBODY
Irving L. Weissman,Benson M. George,Nan Guo Ring,Aaron M. Ring,Jens-Peter Volkmer +4 more
- 08 Jun 2016
TL;DR: In this article, the anti-SIRPα agonist antibodies are described and compared to human SIRPs and activate signaling, thereby inhibiting processes mediated by SIRP, including without limitation phagocytosis.
10
•Journal Article
A cell-surface molecule involved in organ-specific homing of lymphocytes. 1983.
TL;DR: A monoclonal antibody specific for a lymphocyte surface molecule that appears to mediate recognition of lymph node HEV and to be required for lymphocyte homing into lymph nodes in vivo is described.
10
Production of alloreactive T-cell lymphomas
C G Fathman,Irving L. Weissman +1 more
TL;DR: This receptor-mediated leukaemogenesis hypothesis predicts that any T-cell clone that cannot escape its stimulating antigens would appear to be lymphomagenic in that environment.
10